iNKT cells in allergic disease

Current Topics in Microbiology and Immunology

Volumn 314, Issue , 2007, Pages 269-291

  Meyer, E H ^a,b   DeKruyff, R H ^a   Umetsu, D T ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; CORTICOSTEROID; GLYCOLIPID; IMMUNOGLOBULIN E; T LYMPHOCYTE RECEPTOR;

ADAPTIVE IMMUNITY; ALLERGIC DISEASE; ASTHMA; ATOPIC DERMATITIS; BRONCHUS HYPERREACTIVITY; CD4+ T LYMPHOCYTE; CELL FUNCTION; CLINICAL FEATURE; COLITIS; COMPREHENSION; CONTACT SENSITIVITY; DISEASE COURSE; DISEASE MODEL; EFFECTOR CELL; HUMAN; LUNG; MUCOSA; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; TH2 CELL; ULCERATIVE COLITIS; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; HYPERSENSITIVITY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOUSE; NATURAL KILLER CELL; PATHOPHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ASTHMA; HUMANS; HYPERSENSITIVITY; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; T-LYMPHOCYTE SUBSETS; TH2 CELLS;

EID: 34447628055     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-69511-0_11     Document Type: Review

References (91)

1. Umetsu DT, McIntire JJ, Akbari O, Macaubus C, DeKruyff RH (2002) Asthma: an epidemic of dysregulated immunity. Nat Immunol 3:715-720
2. Mannino DM, Homa DM, Pertowski CA et al (1998) Surveillance for asthma - United States, 1960-1995. MMWR CDC Surveill Summ 47:1-27
3. McNally N, Philips D, Williams H (1998) The problem of atopic eczema: aetiological clues from the environment and lifestyles. Soc Sci Med 46:729-741
4. Blumenthal J, Blumenthal MN (1996) Immunogenetics of allergy and asthma. Immunol Allergy Clin North Am 16:517-534
5. Weiss KB, Sullivan SD (2001) The health economics of asthma and rhinitis. I. Asssessing the economic impact. J Allergy Clin Immunol 107:3-8
6. Zaas D, Schwartz DA (2003) Genetics of environmental asthma. Semin Respir Crit Care Med 24:185-195
7. McIntire JJ, Umetsu DT, DeKruyff RH (2004) TIM-1, a novel allergy and asthma susceptibility gene. Springer Semin Immunopathol 25:335-348
8. Blumenthal MN (2005) The role of genetics in the development of asthma and atopy. Curr Opin Allergy Clin Immunol 5:141-145
9. McIntire JJ et al (2005) Hepatitis A virus link to atopic disease. Nature 425:576
10. Umetsu SE, Lee WL, McIntire JJ et al (2005) TIM-1 induces T cell activation and inhibits the development of peripheral tolerance. Nat Immunol 6:447-454
11. Maizels RM (2005) Infections and allergy - helminths, hygiene and host immune regulation. Curr Opin Immunol 17:656-661
12. Blaser K (2004) Allergy and hypersensitivity - From genes to phenotype - Editorial overview. Curr Opin Immunol 16:685-688
13. Upham JW, Holt PG (2005) Environment and development of atopy. Curr Opin Allergy Clin Immunol 5:167-172
14. Kay AB (2001) Advances in immunology: allergy and allergic diseases: first of two parts. N Engl J Med 344:30-37
15. Kay AB (2001) Advances in immunology - allergy and allergic diseases - second of two parts. N Engl J Med 344:109-113
16. Akbari O et al (2006) CD4+ invariant T-cell-receptor plus natural killer T cells in bronchial asthma. N Engl J Med 354:1117-1129
17. Akbari O et al (2003) Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 9:582-588
18. Lisbonne M et al (2003) Cutting edge: invariant V alpha 14.NKT cells dare required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J Immunol 171:1637-1641
19. Mannino DM et al (2002) Surveillance for asthma - United States 1980-1999. MMWR CDC Surveill Summ 51:1
20. Herrick CA, Bottomly K (2003) To respond or not to respond: T cells in allergic asthma. Nat Rev Immunol 3:405-412
21. Robinson DS et al (1992) Predominant Th2-like bronchoalveolar lymphocyte-t population in atopic asthma. N Engl J Med 326:298-304
22. Meyer EH et al (2006) Glycolipid activation of invariant T cell receptor(+) NKT cells is sufficient to induce airway hyperreactivity independent of conventional CD4(+) T cells. Proc Natl Acad Sci U S A 103:2782-2787
23. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L (2004) Opinion - NKT cells: what's in a name? Nat Rev Immunol 4:231-237
24. Taniguchi M, Harada M, Kojo S, Nakayama T, Wakao H (2003) The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Ann Rev Immunol 21:483
25. Brigl M, Brenner MB (2004)CD1: antigen presentation and T cell function. Ann Rev Immunol 2:557
26. Kinjo Y et al (2005) Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434:520-525
27. Zhou DP et al (2004) Lysosomal glycosphingolipid recognition by NKT cells. Science 306:1786-1789
28. Kronenberg M (2005) Toward an understanding of NKT cell biology: progress and paradoxes. Ann Rev Immunol 23:877-900
29. Exley MA, Koziel MJ (2004) To be or not to be NKT: natural killer T cells in the liver. Hepatology 40:1033-1040
30. Seino K, Taniguchi M (2005) Functionally distinct NKT cell subsets and subtypes. J Exp Med 202:1623-1626
31. Godfrey DI, Kronenberg M (2004) Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest 114:1379-1388
32. Mattner J et al (2005) Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434:525-529
33. Zeng DF et al (1999) Bone marrow NK1.1- and NK1.1+ T cells reciprocally regulate acute graft versus host disease. J Exp Med 189:1073-1081
34. Crowe NY et al (2005) Differential antitumor immunity mediated by NKT cell subsets in vivo. J Exp Med 202:1279-1288
35. Cui JQ et al (1999) Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer T cells. J Exp Med 190:783-792
36. Korsgren M et al (1999) Natural killer cell determine development of allergeninduced eosinophilic airway inflammation in mice. J Exp Med 189:553-562
37. Brown DR et al (1996) Beta-2-microglobulin-dependent NK1.1+ T cells are not essential for T helper cell 2 immune responses. J Exp Med 184:1295-1304
38. Zhang Y, Rogers KH, Lewis DB (1996) Beta-2-microglobulin-dependent T cells are dispensable for allergen-induced T helper 2 responses. J Exp Med 184:1507-1512
39. Kim HS et al (1999) Biochemical characterization of CD1d expression in the absence of beta(2)-microglobulin. J Biol Chem 274:9289-9295
40. Amano M et al (1998) CD1 expression defines subsets of follicular and marginal zone B cells in the spleen: beta(2)-microglobulin-dependent and independent forms. J Immunol 161:1710-1717
41. Maeda M, Shadeo A, MacFadyen AM, Takei F (2004) CD1d-independent NKT cells in beta(2)-microglobulin-deficient mice have hybrid phenotype and function of NK and T cells. J Immunol 172:6115-6122
42. Smiley ST, Kaplan MH, Grusby MJ (1997) Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Sci (Washington DC) 275:977-979
43. Kim JO et al (2004) Asthma is induced by intranasal coadministration of allergen and natural killer T-cell ligand in a mouse model. J Allergy Clin Immunol 114:1332-1338
44. Yoshimoto T, Bendelac A, Watson C, Hu-Li K, Paul W (1995) Role of NK1.1+ T cells in Th2 responses and in immunoglobulin E production. Science 270:1845-1847
45. Vonderweid T, Beebe AM, Roopenian DC, Coffman RL (1996) Early production of IL-4 and induction of Th2 responses in the lymph node originate from an MHC class I-independent CD4(+)NK1.1(-)T cell population. J Immunol 157:4421-4427
46. Yoshimoto T, Bendelac A, Huli J, Paul WE (1995) Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1+ T cells that promptly produce interleukin 4. Proc Natl Acad Sci U S A 92:11931-11934
47. Bendelac A, Hunziker RD, Lantz O (1996) Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1 T cells. J Exp Med 184:1285-1293
48. Mattner J et al (2005) Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434:525-529
49. Stein-Streilein J (2003) Invariant NKT cells as initiators, licensors, and facilitators of the adaptive immune response. J Exp Med 198:1779-1783
50. Lin M, Rikihisa Y (2003) Erlichia chaffeensis and Anaplasma phaocytophilum lack genes for lipid A biosynthesis and incorporate cholesterol for their survival. Infect Immun 71:5325
51. Trottein F, Mallevaey T, Faveeuw C, Capron M, Leite-de-Moraes M (2006) Role of the natural killer T lymphocyte in Th2 responses during allergic asthma and helminth parasitic diseases. Chem Immunol Allergy 90:113-127
52. Mallevaey T et al (2006) Activation of invariant NKT cells by the helminth parasite g1 Schistosoma mansoni. J Immunol 176:2476-2485
53. Agea E et al (2005) Human CD1-restricted T cell recognition of lipids from pollens. J Exp Med 202:295-308
54. Ikegami Y, Yokoyama A, Haruta Y, Hiyama K, Kohno N (2004) Circulating natural killer T cells in patients with asthma. J Asthma 41:877-882
55. Sen Y et al (2005) V alpha 24-invariant NKT cells from patients with allergic asthma express CCR9 at high frequency and induce Th2 bias of CD3(+) T cells upon CD226 engagement. J Immunol 175:4914-4926
56. Milner JD et al (1999) Differential responses of invariant V alpha 24J alpha QT cells and MHC class II-restricted CD4(+) T cells to dexamethasone. J Immunol 163:2522-2529
57. Tamada K, Harada M, Abe K, Li TL, Nomoto K (1998) IL-4-producing NK1.1(+) T cells are resistant to glucocorticoid-induced apoptosis: implications for the Th1/Th2 balance. J Immunol 161:1239-1247
58. Adcock IM, Ito K (2004) Steroid resistance in asthma: a major problem requiring novel solutions or a non-issue? Curr Opin Pharmacol 4:257-262
59. Ito K, Chung KF, Adcock IM (2006) Update on glucocorticoid action and resistance. J Allergy Clin Immunol 117:522-543
60. Hachem P et al (2005) Alpha-galactosylceramide-induced iNKT cells suppress experimental allergic asthma in sensitized mice: role of IFN-gamma. Eur J Immunol 35:2793-2802
61. Matsuda H et al (2005) Alpha-galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation. Am J Respir Cell Mol Biol 33:22-31
62. Morishima Y et al (2005) Suppression of eosinophilic airway inflammation by treatment with alpha-galactosylceramide. Eur J Immunol 35:2803-2814
63. Parekh VV, Wilson MT, Van Kaer L (2005) iNKT-cell responses to glycolipids. Crit Rev Immunol 25:183-213
64. Matsuda JL et al (2003) Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo. Proc Natl Acad Sci U S A 100:8395-8400
65. Wang ZY et al (2006) Regulation of Th2 cytokine expression in NKT cells: unconventional use of Stat6, GATA-3, and NFAT2. J Immunol 176:880-888
66. Sherman MA, Secor VH, Lee SK, Lopez RD, Brown MA (1999) STAT6-independent production of IL-4 by mast cells. Eur J Immunol 29:1235-1242
67. Kim CH, Johnston B, Butcher EC (2002) Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity. Blood 100:11-16
68. Gumperz JE, Miyake S, Yamamura T, Brenner MB (2002) Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med 195:625-636
69. Matsuda JL et al (2001) Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor beta repertoire and small clone size. Proc Natl Acad Sci U S A 98:12636-12641
70. Johnston B et al (2003) Differential chemokine responses and homing patterns of murine TCR alpha beta NKT cell subsets. J Immunol 171:2960-2969
71. Mi QS, Ly D, Zucker P, McGarry M, Delovitch TL (2004) Interleukin-4 but not interleukin-10 protects against spontaneous and recurrent type 1 diabetes by activated CD1d-restricted invariant natural killer T-cells. Diabetes 53:1303-1310
72. Sharif S et al (2001) Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat Med 7:1057-1062
73. Benlagha K, Kyin T, Beavis A, Teyton L, Bendelac A (2002) A thymic precursor to the NKT cell lineage. Science 296:481-482
74. MacDonald HR (2002) Development and selection of NKT cells. Curr Opin Immunol 14:250-254
75. Schmieg J, Yang GL, Franck RW, Tsuji M (2003) Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-galactosylceramide. J Exp Med 198:1631-1641
76. Schmieg J, Yang GG, Franck RW, Van Rooijen NV, Tsuji M (2005) Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion. Proc Natl Acad Sci U S A 102:1127-1132 7
77. Bezbradica JS et al (2005) Distinct roles of dendritic cells and B cells in Va14Ja18 natural T cell activation in vivo. J Immunol 174:4696-4705
78. Fujii SI, Liu K, Smith C, Bonito AJ, Steinman RM (2004) The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J Exp Med 199:1607-1618
79. Fujii S, Shimizu K, Kronenberg M, Steinman RM (2002) Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs. Nat Immunol 3:867-874
80. Lan FS, Zeng DF, Higuchi M, Higgins JP, Strober S (2003) Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells. Biol Blood Marrow Transplant 9:355-363
81. Lowsky R et al (2005) Protective conditioning for acute graft-versus-host disease. N Engl J Med 353:1321-1331
82. Heller F, Fuss IJ, Nieuwenhuis EE, Blumberg RS, Strober W (2002) Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 17:629-638
83. Kaser A et al (2004) Natural killer T cells in mucosal homeostasis. In: Weiner H, Mayer L, Strober W (eds) Oral tolerance: new insights and prospects for clinical application. Ann N Y Acad Sci 1029:154-168
84. Hopkin JM (1997) Mechanisms of enhanced prevalence of asthma and atopy in developed countries. Curr Opin Immunol 9:788-792
85. Campos RA et al (2003) Cutaneous immunization rapidly activates liver invariant V alpha-14. NKT cells stimulating B-1B cells to initiate T cell recruitment for elicitation of contact sensitivity. J Exp Med 198:1785-1796
86. Nieuwenhuis EES et al (2005) CD1d and CD1d-restricted iNKT-cells play a pivotal role in contact hypersensitivity. Exp Dermatol 14:250-258
87. Oishi Y et al (2000) CD4(-)CD8(-) T cells bearing invariant V alpha 24J alpha QTCR alpha-chain are decreased in patients with atopic diseases. Clin Exp Immunol 119:404-411
88. Takahashi T et al (2003) Valpha 24(+) natural killer T cells are markedly decreased in atopic dermatitis patients. Hum Immunol 64:586-592
89. Magnan A et al (2000) Relationships between natural T cells, atopy IgE levels, and IL-4 production. Allergy (Copenhagen) 55:286-290
90. Saubermann LJ et al (2000) Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice. Gastroenterology 119:119-128
91. Fuss IJ et al (2004) Nonclassical CD1d-restricted NKT cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest 113:1490-1497